Rosalind Wright Assumes Leadership Roles in Translational Research

Effective November 1, Rosalind Wright, MD, MPH assumed the dual leadership roles of Dean of Translational Biomedical Research and Director of the Clinical and Translational Science Award (CTSA) at the Icahn School of Medicine at Mount Sinai.

As Dean for Translational Biomedical Research, Dr. Wright provides leadership for clinical and population-based research across the Mount Sinai Health System, applying her expertise and vast experience to supporting and growing our research endeavors. This role dovetails with her directorship of the CTSA, recently re-funded by the NIH to foster high-quality translational research, research education, and the development of innovative resources. Through Mount Sinai’s Conduits program, the CTSA spurs collaborations among clinicians, patients, and scientists, and builds partnerships across a national network of CTSA programs.

“As technological advances and evolving insights into disease causation and individual variation increase the complexity of research and its translation into clinical practice, we are challenged with moving forward integrated team science that informs what genes, environment and life stage mean to defining normal variations and altered health trajectories throughout the life course and across generations,” said Dr. Wright of her new roles. “This is an exciting time for science and medicine with Mount Sinai continuing to lead the way.”

Dr. Wright is a Professor in the Departments of Pediatrics and Preventive Medicine. As a pulmonologist and life course epidemiologist, she has special expertise in prenatal and early childhood factors contributing to the programming of chronic diseases. She has built a large National Institutes of Health (NIH)-funded research program focused on understanding the role of both chemical and non-chemical social stressors in perinatal programming of conditions such as asthma, obesity, cardiometabolic disorders, and neurodevelopment, particularly as they relate to health disparities in socioeconomically challenged urban populations. Dr. Wright’s pioneering research on the role of social factors and toxic stress on disease programming starting in pregnancy was recently recognized through her election as a fellow to the National Academy of Behavioral Medicine Research.

As we welcome Dr. Wright, we want to thank Hugh Sampson, MD, who is scaling back his administrative positions at Mount Sinai to assume a role as Chief Scientific Officer for DVB Technologies, a company that is developing treatments for pediatric food allergies. We wish him well in his new external position and, at the same time, are pleased that he will continue to be a visible, vibrant presence in the Icahn School of Medicine research community.


Promotion of Rachel Posner to Associate Dean for Research Administration

On Friday, May 29, 2015, the Office of the Dean announced the appointment of Rachel Posner as Associate Dean for Research Administration at the Icahn School of Medicine at Mount Sinai. As Associate Dean, Ms. Posner’s responsibilities will expand to include Dean’s Office research administration initiatives across the Health System.  She has played a pivotal role in the Research Administration Reengineering initiative, including redesign of the new research portal, and is poised to play a continuing leadership role in this area.

Ms. Posner has been a member of the Mount Sinai community since 2000 and has had an important impact on a range of programs.  Since 2013, she has served as Administrative Director of Translational Research Institutes under the umbrella of the Office of the Dean, providing financial and operational support to the multidisciplinary institutes.  Ms. Posner also played a pivotal role in the development of Conduits – Institutes for Translational Sciences, funded through a National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA).  She was instrumental to the successful 2015 CTSA renewal application, which will enable Conduits to continue to provide educational and programmatic support to move scientific discoveries from the laboratory to clinical practice.

New Director of Education Builds Guidance Resources at the GCO

Have you noticed more emails than usual in your inbox from the GCO, and do you find that a good thing (most of the time)? In June of 2014, the Grants and Contracts Office hired Allison Gottlieb as their new Director of Education for Sponsored Programs, and Allison has been busy reorganizing GCO’s website and creating tools and resources for Mount Sinai’s research community to help them navigate through the submission process. Allison has been working in sponsored project administration at Mount Sinai for 15 years starting her professional career in the GCO as a Grants and Contracts Specialist. Drawing upon that experience, she has created:

  • a master application submission checklist and instructions, which enables PIs and their teams to submit virtually administrative error free applications when followed;
  • a budget template in Excel with automatic calculation features to handle the simplest and toughest budgets out there;
  • SOP memos and checklists for projects with subawards;  and
  • a series of NIH specific guidance such as for ASSIST grants and required Individual Development Plan (IDP) language for use in RPPR applications.

If you would like to receive GCO’s e-communications and stay up to date on changes that may affect your application submission, please send an e-mail to

Welcoming Diane Winiarski, Radiation Safety Analyst

Diane Winiarksi, RN, BSN joined the PPHS team in October 2014 as the new Radiation Safety Analyst. She plays a key role in the processing and evaluation of all human subject research protocols employing ionizing radiation in research. She joined Mount Sinai in 2011 in the Department of Risk Management and brings over twenty years of diverse experience in clinical research, patient advocacy, clinical risk management, performance improvement, and record review. With her firm knowledge base in HIPAA and corporate compliance and her strong history of patient and research participant advocacy, she provides expert support for both researchers and administration alike.